APGE Downgraded
Deutsche Bank downgrades Apogee Therapeutics to Hold and raises price target to $135
Deutsche Bank Downgrades Apogee Therapeutics to Hold, Raises Price Target to $135
Deutsche Bank downgrades Apogee Therapeutics to Hold and raises price target to $135
Deutsche Bank Downgrades Apogee Therapeutics to Hold, Raises Price Target to $135